Sera Prognostics Inc develops innovative diagnostic tests that predict the risk of premature birth, preeclampsia, and other complications of pregnancy. The company's PreTRM® Test provides physicians with individualized risk information about premature delivery, enabling proactive interventions in patients with higher risk. Sera's biomarker-based tests deliver pivotal information to physicians early in pregnancy to improve patient health and reduce healthcare costs. The company is also developing a pipeline of tests for other pregnancy complications, including preeclampsia, gestational diabetes, and growth restriction. Visit Sera's website to learn more about their values, culture, and job openings.